GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » EV-to-EBIT

Cognetivity Neurosciences (Cognetivity Neurosciences) EV-to-EBIT : -0.75 (As of May. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cognetivity Neurosciences's Enterprise Value is $2.29 Mil. Cognetivity Neurosciences's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was $-3.05 Mil. Therefore, Cognetivity Neurosciences's EV-to-EBIT for today is -0.75.

The historical rank and industry rank for Cognetivity Neurosciences's EV-to-EBIT or its related term are showing as below:

CGNSF' s EV-to-EBIT Range Over the Past 10 Years
Min: -4.74   Med: -2.86   Max: -0.69
Current: -0.75

During the past 7 years, the highest EV-to-EBIT of Cognetivity Neurosciences was -0.69. The lowest was -4.74. And the median was -2.86.

CGNSF's EV-to-EBIT is ranked worse than
100% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 18.01 vs CGNSF: -0.75

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cognetivity Neurosciences's Enterprise Value for the quarter that ended in Oct. 2023 was $11.24 Mil. Cognetivity Neurosciences's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was $-3.05 Mil. Cognetivity Neurosciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 was -27.10%.


Cognetivity Neurosciences EV-to-EBIT Historical Data

The historical data trend for Cognetivity Neurosciences's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences EV-to-EBIT Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
EV-to-EBIT
Get a 7-Day Free Trial -4.26 -3.70 -22.52 -3.21 -3.17

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.52 -3.17 -5.10 -3.68 -3.29

Competitive Comparison of Cognetivity Neurosciences's EV-to-EBIT

For the Health Information Services subindustry, Cognetivity Neurosciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's EV-to-EBIT falls into.



Cognetivity Neurosciences EV-to-EBIT Calculation

Cognetivity Neurosciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.289/-3.047
=-0.75

Cognetivity Neurosciences's current Enterprise Value is $2.29 Mil.
Cognetivity Neurosciences's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (OTCPK:CGNSF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cognetivity Neurosciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Oct. 2023 ) =EBIT / Enterprise Value (Q: Oct. 2023 )
=-3.047/11.24315244
=-27.10 %

Cognetivity Neurosciences's Enterprise Value for the quarter that ended in Oct. 2023 was $11.24 Mil.
Cognetivity Neurosciences's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019